Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Unbelievable to me that Stada
View:
Post by Oceanis on Oct 28, 2021 8:35pm

Unbelievable to me that Stada

hasn't helped out these guys with an institutional investment.  At this point I think they are working against cannabis becoming a viable alternative to symthetic medicines.  Fuk you Stada.
Comment by mcamm10 on Oct 28, 2021 8:45pm
This post has been removed in accordance with Community Policy
Comment by Oceanis on Oct 29, 2021 4:59am
pharmacuetical companies have a vested interest in making sure cannabis doesn't become mainstream within medicine.  There's a fox in the henhouse imo.  In any case LABS doesnt need stada, so this new CEO better have a plan b. Or explain their buisness plan better, because all these partnerships with all these companies to date are fuk all to the shareholders.   They're ...more  
Comment by Righttothetop on Oct 29, 2021 7:24am
You and every shareholder (me included) has and should be pissed right off with how LABS has performed over the past few years.  Going from $7 to $0.26 is no small achievement.....and it takes efforts to be that bad.....which is infuriating. And I agree, the partnerships they have spent years signing need to start bearing fruit.  I think they thought as they were signing them that the ...more  
Comment by mcamm10 on Oct 29, 2021 11:12am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities